Skip to main content
TipRanks
Go Ultimate75% OFF

IM Cannabis Corp (IMCC) Q1 2025 Earnings Report

188 Followers

IMCC Q1 2025 EPS Results

Actual EPS
$0.09
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
-$55.10

IMCC Q1 2025 Revenue Results

Actual Revenue
$12.50M
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
+39.75%

Earnings Announcement Details

Quarter
Q1 2025
Date
05/15/2025
Time
Before Open
Conference Call
Thursday, May 15, 2025
IMCC Upcoming Earnings

IM Cannabis Corp's next earnings date is estimated for April 1, 2027, based on past reporting schedules.

Q1 2025 Earnings Call Audio

IMCC Q1 2025 Earnings Call
0:00 / 0:00

Q1 2025 Earnings Slide Deck

No slide deck is available for this earnings event.

Q1 2025 Earnings Call Summary

Q1 2025
Earnings Call Date:May 15, 2025|% Change Since:-98.82%|
Earnings Call Sentiment|Positive

The earnings call for IM Cannabis reflected a positive sentiment, with the company achieving net profitability and substantial growth in the German market, despite a decline in Israeli revenue and increased liabilities.

Company Guidance

During the Q1 2025 earnings call, IM Cannabis reported a significant turnaround with a net profit of $0.2 million, contrasting with a $6 million loss in Q1 2024. The company achieved an adjusted EBITDA profit of $0.6 million, representing an improvement of almost $3 million compared to the previous year's loss of $2.2 million. Revenues increased by 4% to $12.5 million, driven by a remarkable 569% growth in the German market, which now represents 62% of total revenue. This growth in Germany offset a 56% decline in Israeli revenue. The gross margin improved by 87%, and gross profit surged 94% to $3.4 million, aided by strategic cost-cutting measures that reduced operating expenses by 56%. Total assets grew by 15%, reflecting increased trade receivables, inventory, and advances to suppliers. The company plans to continue financing operations through existing resources and available credit facilities while exploring additional capital sources.

  • Net Profit Achieved in Q1 2025IM Cannabis achieved a net profit of approximately $0.2 million in Q1 2025, marking a significant turnaround from a loss of $6 million in Q1 2024.
  • Substantial Growth in German MarketRevenue in the German market grew by 569% compared to Q1 2024, significantly contributing to the company's financial turnaround.
  • Improvement in Gross MarginThe gross margin improved by 87% compared to Q1 2024, indicating increased operational efficiency.
  • Increase in Gross ProfitGross profit increased by 94%, from $1.8 million in Q1 2024 to $3.4 million in Q1 2025.
  • Reduction in Operating ExpensesOperating expenses decreased by 56% in Q1 2025 compared to Q1 2024, demonstrating cost control and efficiency.
  • Positive Adjusted EBITDAThe company reported a positive adjusted EBITDA of $0.6 million, an improvement from a loss of $2.2 million in Q1 2024.

IMCC Earnings History

IMCC earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Apr 01, 20272026 (Q4)―--8.4――
Nov 13, 20262026 (Q3)―-3.06-16.0680.92% (+12.99)
Aug 13, 20262026 (Q2)―-10.20-1.96-420.31% (-8.24)
May 13, 20262026 (Q1)―-8.401.93-535.41% (-10.33)
Mar 30, 20262025 (Q4)―-27.86-6.67-317.74% (-21.19)
Nov 13, 20252025 (Q3)―-16.06-8.78-82.95% (-7.28)
Aug 12, 20252025 (Q2)―-1.96-5.0461.10% (+3.08)
May 15, 20252025 (Q1)―0.09-55.1100.16% (+55.19)
Mar 31, 20252024 (Q4)-7.641.93-55.1103.50% (+57.03)
Nov 14, 20242024 (Q3)-21.03-8.78-20.8757.94% (+12.09)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed